First Horizon Names Jeffrey R. Balser, M.D., Ph.D. to its Board of Directors
First Horizon (NYSE: FHN) elected Jeffrey R. Balser as an independent director of both its corporate and bank boards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
First Horizon (NYSE: FHN) elected Jeffrey R. Balser as an independent director of both its corporate and bank boards.
Balser is president and chief executive officer of Vanderbilt University Medical Center and dean of Vanderbilt University School of Medicine. He has led the medical center since 2009 and guided its 2016 legal and financial separation from Vanderbilt University into an independent, not-for-profit corporation. His earlier roles included chair of anesthesiology and chief research officer at the medical center.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dr. Balser is the President, Chief Executive Officer and a member of the board of directors of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine.
Dr. Balser is President and Chief Executive Officer of Vanderbilt University Medical Center (VUMC), an academic health system based in
Prior to his current role, Dr. Balser served as chair of anesthesiology and later as chief research officer at VUMC and practiced cardiac anesthesiology and cardiac intensive care medicine at VUMC and, before 1998, at Johns Hopkins, where he led a research program funded by the National Institutes of Health. He was named Dean of Medicine and Vice Chancellor for Health Affairs in 2008-2009, with his responsibilities expanding in 2016 to President and CEO of VUMC.
"Jeff brings a rare combination of large-enterprise leadership, financial discipline and deep community ties to our board," said Bryan Jordan, Chairman of the Board, President and CEO of First Horizon. "He has grown one of the nation's leading academic health systems while navigating complex regulatory, risk and governance challenges, and his perspective will strengthen our board as we continue to serve our clients and communities across the Southeast."
"We are pleased to welcome Jeff to the board," said John Compton, First Horizon Lead Director. "His experience leading a major
Dr. Balser holds a B.S. in Engineering from Tulane University (1984) and an M.D./Ph.D. in pharmacology from Vanderbilt University (1990).
For more information about the First Horizon Board of Directors, please visit: Corporate Governance - Board of Directors - First Horizon Corporation.
About First Horizon
First Horizon Corp. (NYSE: FHN), with
View original content to download multimedia:https://www.prnewswire.com/news-releases/first-horizon-names-jeffrey-r-balser-md-phd-to-its-board-of-directors-302919743.html
SOURCE First Horizon Corporation